
    
      To confirm the efficacy of the 75 IU dose of Luveris® compared to placebo when administered
      concomitantly with follitropin alfa for induction of clinical pregnancy in women with
      hypogonadotropic hypogonadism and profound LH deficiency (LH <1.2 IU/L), and to study the
      efficacy of a lower dose (25 IU) of Luveris® compared to placebo when administered
      concomitantly with follitropin alfa for induction of follicular development in women with
      hypogonadotropic hypogonadism and profound LH deficiency (LH <1.2 IU/L).
    
  